Reaching MDG 4 in India: A role for rotavirus vaccine?

Clinical Infectious Diseases

Volumn 52, Issue 2, 2011, Pages 178-179

  Nelson, Edmund Anthony S ^a   Walker, Damian G ^b,c  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b BILL AND MELINDA GATES FOUNDATION   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; ROTAVIRUS VACCINE;

COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; EDITORIAL; GOVERNMENT REGULATION; HUMAN; INDIA; MASS IMMUNIZATION; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; ROTAVIRUS INFECTION;

CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; HEALTH POLICY; HUMANS; INDIA; INFANT; INFANT, NEWBORN; MODELS, STATISTICAL; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINATION;

EID: 79951832328     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciq095     Document Type: Editorial

References (11)

1. Nelson EA, Sack D, Wolfson L, Walker DG, Seng LF, Steele D. Financing children's vaccines. Vaccine 2009;27: F12-F17.
2. Flannery B, de Oliveira LH. How have rotavirus vaccines worked in developing countries in Latin America? Available at: http://www.sabin.org/files/ uploads/B%20Flannery pdf. Accessed 15 October 2010.
3. Thiry G. What does the rotavirus vaccine pipeline look like? Available at: http://www.sabin.org/files/uploads/THIRY.pdf. Accessed 15 October 2010.
4. John TJ. India's National Technical Advisory Group on Immunisation. Vaccine 2010;28: A88-A90.
5. Rose J, Hawthorn RL, Watts B, Singer ME. Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis. BMJ 2009;339: b3653.
6. Kang G. Protection conferred by natural rotavirus infection and against subsequent infection and disease in an Indian birth cohort Available at: http://www.sabin.org/files/uploads/Kang.pdf. Accessed 15 October 2010.
7. Velazquez FR, Matson DO, Calva JJ, et al. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med 1996;335:1022-8. (Pubitemid 26338732)
8. Tate JE, Chitambar S, Esposito DH, et al. Disease and economic burden of rotavirus diarrhoea in India. Vaccine 2009;27: F18-F24.
9. Zaman K, Dang DA, Victor JC, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 2010;376:615-23.
10. UNDP. Available at: http://content.undp.org/go/newsroom/2010/september/ achieving-mdgs-in-india en. Accessed 15 October 2010.
11. Esposito DH, Tate JE, Kang G, et al. Projected Impact and Cost-Effectiveness of a Rotavirus Vaccination Program in India, 2008. CID 2011;52:171-177.